循环肿瘤细胞检测在胃癌中的临床应用

国际肿瘤学杂志››2015,Vol. 42››Issue (6): 466-468.doi:10.3760/cma.j.issn.1673-422X.2015.06.018

循环肿瘤细胞检测在胃癌中的临床应用

陆信仰,崔凯,李胜

272100济宁医学院附属医院胃肠外科（陆信仰）；山东省肿瘤医院肝胆外科（崔凯、李胜）

收稿日期:2014-12-15出版日期:2015-06-08发布日期:2015-05-31
通讯作者:李胜，Email:drlisheng@sohu.com E-mail:drlisheng@sohu.com
基金资助:

国家重点基础研究发展计划（2011CB504300）

Clinical applications of circulating tumor cells detection in gastric carcinoma

Lu Xinyang, Cui Kai, Li Sheng

Department of Gastrointestinal Surgery, Affiliated Hospital of Jining Medical College, Jining 272100, China

Received:2014-12-15Online:2015-06-08Published:2015-05-31
Contact:Li Sheng E-mail:drlisheng@sohu.com

摘要/Abstract

摘要：循环肿瘤细胞(CTC)为存在于肿瘤患者外周血的一类特殊细胞，目前CTC检测已应用于胃癌患者生存期预测、术后复发的检测及个体化治疗指导等方面。随着研究的不断深入，CTC将为胃癌的综合治疗提供新的帮助。

陆信仰,崔凯,李胜. 循环肿瘤细胞检测在胃癌中的临床应用[J]. 国际肿瘤学杂志, 2015, 42(6): 466-468.

Lu Xinyang, Cui Kai, Li Sheng. Clinical applications of circulating tumor cells detection in gastric carcinoma[J]. Journal of International Oncology, 2015, 42(6): 466-468.

［1］ Uenosono Y, Arigami T, Kozono T, et al. Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer［J］. Cancer, 2013, 119(22): 3984-3991. ［2］ Steinert G, Schlch S, Koch M, et al. Biology and significance of circulating and disseminated tumour cells in colorectal cancer［J］. Langenbecks Arch Surg, 2012, 397(4): 535-542. ［3］ Hong B, Zu Y. Detecting circulating tumor cells: current challenges and new trends［J］. Theranostics, 2013, 3(6): 377-394. ［4］ Vaiopoulos AG, Kostakis ID, Gkioka E, et al. Detection of circulating tumor cells in colorectal and gastric cancer using a multiplex PCR assay［J］. Anticancer Res, 2014, 34(6): 3083-3092. ［5］ Dardaei L, Shahsavani R, Ghavamzadeh A, et al. The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative realtime PCR［J］. Clin Biochem, 2011, 44(4): 325-330. ［6］ Arigami T, Uenosono Y, Hirata M, et al. B7H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells［J］. Cancer Sci, 2011, 102(5): 1019-1024. ［7］ Tsujiura M, Ichikawa D, Konishi H, et al. Liquid biopsy of gastric cancer patients: circulating tumor cells and cellfree nucleic acids［J］. World J Gastroenterol, 2014, 20(12): 3265-3286. ［8］ Zheng Y, Cui L, Sun W, et al. MicroRNA21 is a new marker of circulating tumor cells in gastric cancer patients［J］. Cancer Biomark, 2011—2012, 10(2): 71-77. ［9］ Raimondi C, Gradilone A, Naso G, et al. Clinical utility of circulating tumor cell counting through CellSearch(?): the dilemma of a concept suspended in Limbo［J］. Onco Targets Ther, 2014, 7: 619-625. ［10］ Hou JM, Krebs MG, Lancashire L, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with smallcell lung cancer［J］. J Clin Oncol, 2012, 30(5): 525-532. ［11］ Sirop S, Kanaan M, Korant A, et al. Detection and prognostic impact of micrometastasis in colorectal cancer［J］. J Surg Oncol, 2011, 103(6): 534-537. ［12］ Hwang SG, Kim KM, Cheong JH, et al. Impact of pretreatment thrombocytosis on bloodborne metastasis and prognosis of gastric cancer［J］. Eur J Surg Oncol, 2012, 38(7): 562-567. ［13］ Zhang ZY, Ge HY. Micrometastasis in gastric cancer［J］. Cancer Lett, 2013, 336(1): 34-45. ［14］ Yoneda A, Taniguchi K, Torashima Y, et al. The detection of gastric cancer cells in intraoperative peritoneal lavage using the reverse transcriptionloopmediated isothermal amplification method［J］. J Surg Res, 2014, 187(1): e1-6. ［15］ Cao W, Yang W, Li H, et al. Using detection of survivinexpressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer［J］. J Surg Oncol, 2011, 103(2): 110-115. ［16］ Arigami T, Uenosono Y, Ishigami S, et al. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer［J］. Oncol Rep, 2013, 30(6): 2838-2844. ［17］ Farace F, Massard C, Vimond N, et al. A direct comparison of CellSearch and ISET for circulating tumourcell detection in patients with metastatic carcinomas［J］. Br J Cancer, 2011, 105(6): 847-853. ［18］ Hiraiwa K, Takeuchi H, Hasegawa H, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers［J］. Ann Surg Oncol, 2008, 15(11): 3092-3100. ［19］ Matsusaka S, Chìn K, Ogura M, et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer［J］. Cancer Sci, 2010, 101(4) :1067-1071. ［20］ Khushalani NI. Phase Ⅰ and Ⅱ clinical trials for gastric cancer［J］. Surg Oncol Clin N Am, 2012, 21(1): 113-128. ［21］ Galletti G, Sung MS, Vahdat LT, et al. Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2based microfluidic device［J］. Lab Chip, 2014, 14(1): 147-156. ［22］ Ross JS. Update on HER2 testing for breast and upper gastrointestinal tract cancers［J］. Biomark Med, 2011, 5(3): 307-318.

[1]	钱晓涛, 石子宜, 胡格, 吴晓维.Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效：一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[5]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[6]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[7]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[8]	王培鑫, 赵军, 徐世红, 姜朝阳, 王小强, 杨红娟.铁死亡相关机制在骨肉瘤中的应用进展[J]. 国际肿瘤学杂志, 2024, 51(5): 308-311.
[9]	王昆, 周中新, 臧其威.血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 198-203.
[10]	胡婷婷, 王越华.电子鼻与线虫鼻——新型早期癌症筛查工具[J]. 国际肿瘤学杂志, 2024, 51(4): 223-226.
[11]	萨蔷, 徐航程, 王佳玉.乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234.
[12]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙.肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[13]	王子豪, 王宇, 杨鑫, 何艺, 莫兴奎, 袁涛.铁死亡在骨肉瘤中的分子机制及相关治疗的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 239-244.
[14]	张栋岩, 王品, 魏秋亚, 邓成伍, 魏相相, 高远飞, 王琛.索凡替尼靶向联合卡培他滨和奥沙利铂治疗肝内胆管癌术后患者1例及文献复习[J]. 国际肿瘤学杂志, 2024, 51(4): 249-253.
[15]	严爱婷, 王翠竹, 刘春桂, 鲁小敏.卡瑞利珠单抗与信迪利单抗治疗晚期非小细胞肺癌的临床疗效及安全性分析[J]. 国际肿瘤学杂志, 2024, 51(3): 137-142.